- Home
- QTRX vs TARA Comparison
QTRX vs TARA Comparison
Compare QTRX & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- TARA
- Stock Information
- Founded
- QTRX 2007
- TARA N/A
- Country
- QTRX United States
- TARA United States
- Employees
- QTRX N/A
- TARA N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QTRX Industrials
- TARA Health Care
- Exchange
- QTRX Nasdaq
- TARA Nasdaq
- Market Cap
- QTRX 241.2M
- TARA 220.7M
- IPO Year
- QTRX 2017
- TARA N/A
- Fundamental
- Price
- QTRX $5.95
- TARA $5.78
- Analyst Decision
- QTRX Hold
- TARA Strong Buy
- Analyst Count
- QTRX 4
- TARA 6
- Target Price
- QTRX $11.75
- TARA $19.80
- AVG Volume (30 Days)
- QTRX 425.0K
- TARA 887.3K
- Earning Date
- QTRX 11-11-2025
- TARA 11-11-2025
- Dividend Yield
- QTRX N/A
- TARA N/A
- EPS Growth
- QTRX N/A
- TARA N/A
- EPS
- QTRX N/A
- TARA N/A
- Revenue
- QTRX $125,784,000.00
- TARA N/A
- Revenue This Year
- QTRX N/A
- TARA N/A
- Revenue Next Year
- QTRX $37.89
- TARA N/A
- P/E Ratio
- QTRX N/A
- TARA N/A
- Revenue Growth
- QTRX N/A
- TARA N/A
- 52 Week Low
- QTRX $4.05
- TARA $1.77
- 52 Week High
- QTRX $15.67
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- QTRX 60.51
- TARA 79.50
- Support Level
- QTRX $5.60
- TARA $5.20
- Resistance Level
- QTRX $6.20
- TARA $5.88
- Average True Range (ATR)
- QTRX 0.33
- TARA 0.37
- MACD
- QTRX 0.01
- TARA 0.09
- Stochastic Oscillator
- QTRX 73.44
- TARA 92.31
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).